Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 240

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 240
---
 Saddle River,                                      
 NJ 07458.                                                                                                                                 |

| (4) | Shares owed by Ms. Merchant are Ordinary Shares subject to outstanding stock options which are exercisable 
 at December 31, 2024 or will become exercisable within 60 days after such date.                            |

| (5) | Shares owed by Dr. Parker are Ordinary Shares subject to outstanding stock options which are exercisable 
 at December 31, 2024 or will become exercisable within 60 days after such date.                          |

| (6) | Shares owned by Mr. Stamp are Ordinary Shares subject to outstanding stock options which are exercisable 
 at December 31, 2024 or will become exercisable within 60 days after such date.                          |

| (7) | Shares owned by Dr. Turton include 7,200,000 Ordinary Shares subject to outstanding stock options which 
 are exercisable at December 31, 2024 or will become exercisable within 60 days after such date.         |

| (8) | Shares owed by Dr. de Vries are Ordinary Shares subject to outstanding stock options which are exercisable 
 at December 31, 2024 or will become exercisable within 60 days after such date.                            |

| (9) | Shares owed by all directors and senior management as a group include 57,518,875 Ordinary Shares subject                            
 to outstanding stock options, which are exercisable at December 31, 2024 or will become exercisable within 60 days after such date. |

As of December 31, 2024, approximately
0.01% of our outstanding Ordinary Shares was held by registered shareholders with addresses in the United Kingdom (excluding shares held
by the custodian under our depositary agreement with JPMorgan Chase Bank, N.A.), and we had 189 holders of record in the United Kingdom.
As of December 31, 2024, JPMorgan Chase Bank, N.A., as depositary for the Depositary Shares, held 6,392,362,427 Ordinary Shares, representing
95.6% of the issued share capital held at that date. As of December 31, 2024, we had five registered holders with an address in the United
States. The number of holders of record or registered holders in the United States or United Kingdom is not representative of the number
of beneficial holders or of the residence of beneficial holders.

Based on our share register,
we believe that we are not directly or